English | 繁體

Search in the results

UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Research and development of mAb drugs in China: a look from policy perspectives Journal article
Rong Jiang, Yuanyuan Sun, Carolina Ung, Xinyue Dong, Xiangjun Kong, Yuanjia Hu, Rong Shao. Research and development of mAb drugs in China: a look from policy perspectives[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15(11), 2695-2705.
Authors:  Rong Jiang;  Yuanyuan Sun;  Carolina Ung;  Xinyue Dong;  Xiangjun Kong; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:4.1/4.2 | Submit date：2020/03/12
r&d Support And Guidance Policy  Clinical Trial Policy  Drug Lag  Innovation Support System  Mab Drugs  Marketing Approval Policy  
PHP51 Utilization of monoclonal antibody in China: a study from national market access view Conference paper
Lai, Y., Bie, R., Suo, S., Shi, H., Chen, S., Ung, O. L. C., Hu, H.. PHP51 Utilization of monoclonal antibody in China: a study from national market access view[C], 2018, S159-S159.
Authors:  Lai, Y.;  Bie, R.;  Suo, S.;  Shi, H.;  Chen, S.; et al.
Favorite |  | Submit date：2022/07/27
mAb  market access  
Trends involving monoclonal antibody (mAb) research and commercialization: A scientometric analysis of IMS Lifecycle R&D Focus Database (1980-2016) Journal article
Yunfeng Lai, Sizhuo Suo, Ruibing Wang, Xiangjun Kong, Yuanjia Hu, Daisheng Tang, Honghao Shi, Shengqi Chen, Hao Hu. Trends involving monoclonal antibody (mAb) research and commercialization: A scientometric analysis of IMS Lifecycle R&D Focus Database (1980-2016)[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14(4), 847-855.
Authors:  Yunfeng Lai;  Sizhuo Suo;  Ruibing Wang;  Xiangjun Kong;  Yuanjia Hu; et al.
Favorite | TC[WOS]:8 TC[Scopus]:11  IF:4.1/4.2 | Submit date：2020/04/06
Technology Commercialization  Citespace  Ims  Mab  Monoclonal Antibody  
Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980–2016) Journal article
Lai,Yunfeng, Wang,Ruibing, Chen,Xin, Tang,Daisheng, Hu,Yuanjia, Cai,Jing, Zhang,Qingwen, Hu,Hao. Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980–2016)[J]. Human Vaccines and Immunotherapeutics, 2017, 13(6), 1388-1397.
Authors:  Lai,Yunfeng;  Wang,Ruibing;  Chen,Xin;  Tang,Daisheng;  Hu,Yuanjia; et al.
Favorite | TC[WOS]:16 TC[Scopus]:22  IF:4.1/4.2 | Submit date：2021/03/01
Citespace  Intellectual Landscape  Mab  Monoclonal Antibody  Scientometric  
Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980-2016) Journal article
Lai, Yunfeng, Wang, Ruibing, Chen, Xin, Tang, Daisheng, Hu, Yuanjia, Cai, Jing, Zhang, Qingwen, Hu, Hao. Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980-2016)[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13(6), 1388-1397.
Authors:  Lai, Yunfeng;  Wang, Ruibing;  Chen, Xin;  Tang, Daisheng;  Hu, Yuanjia; et al.
Favorite | TC[WOS]:16 TC[Scopus]:22  IF:4.1/4.2 | Submit date：2018/10/30
Citespace  Intellectual Landscape  Monoclonal Antibody  Mab  Scientometric  
Human monoclonal antibodies to IGF1/2 with picomolar affinity Journal article
Qi Zhao, Yang Feng, Zhongyu Zhu, Dimiter S. Dimitrov. Human monoclonal antibodies to IGF1/2 with picomolar affinity[J]. MOLECULAR CANCER THERAPEUTICS, 2011, 10(9), 1677-1685.
Authors:  Qi Zhao;  Yang Feng;  Zhongyu Zhu;  Dimiter S. Dimitrov
Favorite | TC[WOS]:35 TC[Scopus]:36  IF:5.3/5.4 | Submit date：2019/01/23
Mab  Igf2  Picomolar Affinity  Phage Display  Yeast Display  Igf1